Objective/Hypothesis: It is reasonable to suppose that the pattern of sensorineural damage along the length of the cochlea depends on the etiology of a hearing loss (HL). In GJB2-related deafness, we hypothesize that gap junction deficits are uniformly distributed and will result in similar damage along the length of the cochlea as compared with non-GJB2 subjects. We assessed this by measuring patterns of neural activity and hearing from apical versus basal cochlear implant electrode regions. Study Design: This was a prospective, blind, controlled study. Methods: Blood from 301 pediatric cochlear implant users was analyzed for mutations in GJB2 by direct sequencing. After exclusion of patients with monoallelic GJB2 mutations, associated syndromes, or risk factors for HL that were not congenital, 39 children with biallelic GJB2 mutations and 58 without GJB2 mutations were evaluated. Hearing was measured before implantation at frequencies ranging from 250 Hz to 8 kHz. After implantation, neural activity at the apical and basal ends of the implanted array was measured using electrically evoked compound action potentials of the auditory nerve (ECAPs) and evoked stapedius reflexes (ESRs). Results: GJB2 and non-GJB2 groups were not significantly different with respect to sex, age at implantation, duration of auditory deprivation, hearing aid use, duration of aided hearing, ear implanted, implant model, or depth of insertion (P > .05). Children with GJB2-related HL had greater similarities between low-and high-frequency residual hearing and between neural activity electrically evoked at apical and basal regions of the cochlea as compared with children with non-GJB2-related HL who demonstrated larger deficits in basal regions. Conclusion: Results suggest more consistent spiral ganglion survival along the length of the cochlea in GJB2-related HL as compared with non-GJB2-related HL, which appears to involve a decreasing gradient of spiral ganglion survival from the apex to the base of the cochlea. Our findings support our premise that in GJB2-related HL, dysfunction of gap junctions likely occurs to a similar degree in the apical and basal regions of the cochlea. This knowledge might be used to customize implantable devices for patients with HL in the future.
INTRODUCTION
GJB2-related hearing loss (HL) is believed to result from altered potassium recirculation in the cochlea without direct involvement of the auditory nerve. 1, 2 Although one temporal bone study provided anatomic evidence for good preservation of auditory nerve spiral ganglion cells in GJB2-related HL, 3 further evidence from physiological testing of the auditory system in subjects with GJB2 deafness has not yet been reported. The objective of this study was to evaluate cochlear neural function in pediatric patients with cochlear implants with and without GJB2-related HL by measuring the auditory-evoked compound action potential (ECAP), evoked stapedial reflex (ESR), and residual hearing preimplantation. Our specific hypothesis was that GJB2 mutations affect gap junctions equally along the length of the cochlea resulting in a uniform pattern of sensorineural damage. We asked if this correlates with a uniform pattern of neural activity and hearing from apical to basal cochlear electrode regions.
Autosomal recessive nonsyndromic HL is the most prevalent genetic cause of congenital HL and 50% of cases are the result of mutations in the GJB2 gene. The GJB2 gene encodes the connexin 26 (Cx26) protein, which is a component of gap junctions. Gap junctions in the cochlea allow potassium ions to be removed from the endolymph to the stria vascularis to maintain endolymphatic homeostasis. 2 Mutations in Cx26 are presumed to result in altered potassium recirculation, leading to accumulation of potassium in the cochlear endolymph and causing hair cell dysfunction and deafness. 1 Over 100 Cx26 mutations known to cause HL have been reported in over 35 different countries. 4, 5 Congenital HL has long been associated with degeneration of spiral ganglion cells, which is most severe in the basal turn, as compared with the apical turn, of the cochlea. 6 GJB2-related HL may be different, because in a rat model, Cx26 was shown to be expressed in nonsensory epithelial and connective tissue cells, but not in the inner or outer hair cells or cochlear nerve fibers. 2 Jun et al. evaluated the temporal bone of one individual with GJB2-related deafness and found no degeneration of the auditory nerve and a normal population of spiral ganglion cells in both the apical and basal turns of the cochlea. Because success with a cochlear implant is dependent on the survival and electrical excitability of cochlear spiral ganglion cells and the auditory nerve, 7 it is important to understand the pattern of spiral ganglion survival in GJB2-related HL.
Although evaluation of the auditory system in GJB2-related deafness has been inferred through measurement of speech and language testing, direct evaluation of the auditory nerve in GJB2-related deafness has not yet been reported. Our specific interest is in the possible homogeneity of cochlear neural damage, and we attempt to quantify this. We have used the auditory ECAP, because this has previously been correlated to auditory nerve spiral ganglion cell survival. 8 We also compare apically versus basally evoked ESRs in addition to residual hearing preimplantation in pediatric cochlear implant users having GJB2 versus non-GJB2-related HL.
MATERIALS AND METHODS

Subjects
Subjects were pediatric cochlear implant users with severe to profound HL. This project was approved by The Hospital for Sick Children Ethics Review Board. Blood was prospectively obtained from 301 patients after obtaining written consent from each child's parent/guardian. Patients with congenital, nonsyndromic HL and either biallelic or no GJB2 mutations were included. Individuals with GJB2 mutations on only one allele were excluded. Individuals with associated syndromes or risk factors for HL that were not genetic in nature were excluded (Table I) . Characteristics of patients included in this study appear in Table  II. All cochlear implant recipients underwent a trial of hearing aid use before surgery. The period of auditory deprivation was defined as the time from birth until acquisition of hearing aids. The period of aided hearing was defined as the time from acquisition of hearing aids until implantation. Unaided preimplant audiograms for the implanted ear obtained closest to the date of implantation were evaluated. To statistically distinguish between responses and nonresponses at a given frequency, the latter were assigned a value of 10 units above the maximum testable intensity for that frequency allowed by the GSI 61 Clinical Audiometer (Grason-Stadler Inc., Madison, WI) (Table III) . Four models of Nucleus 24 (Cochlear Corp., Melbourne, Australia) cochlear implants were used: 1) CI24M, which has a straight electrode array, 2) CI24R (ST), which has a straight electrode array and a rounder receiver-stimulator, 3) CI24R (CS), which has a curved electrode array that positions it adjacent to the modiolus, and 4) CI24R (CA), which has a curved electrode array and a soft tip for less traumatic insertion.
GJB2 Mutation Detection
DNA was extracted from whole blood using high salt (Gentra Systems, Inc., Minneapolis, MN) or spin column (Qiagen Inc., Valencia, CA) methods. Mutation detection for GJB2 was performed by direct sequencing of the coding region (exon2) and the intron/exon boundaries of the gene. Polymerase chain reactions (PCRs) contained in a 50 L volume 200 ng genomic DNA, 10 pmol each primer, 2.0 mmol/L buffer (2.0 mmol/L MgCl2, 500 mmol/L KCl, 100 mmol/L Tris-HCl, pH 8.8), 200 M each dNTP (dATP, dCTP, dTTP, dGTP; Amersham Pharmacia Biotech), and 1.5 U Taq polymerase (Amplitaq Gold; Roche Pharmaceuticals, Nutley, NJ). PCR conditions used were initial denaturation of 95°C for 10 minutes; touchdown step cycle (15 cycles) 95°C for 30 seconds, 64.5°C to 57°C decreasing 0.5°C per cycle, 72°C for 30 seconds; cycle (20 cycles) 95°C for 30 seconds, 57°C for 30 seconds, 72°C for 30 seconds; and final extension of 72°C for 2 minutes. PCR products were purified with a PCR purification kit (PCR Purification Kit; Qiagen) and 5 ng used in fluorescent dye terminator cycle sequencing (BigDye Terminator kit; Applied Biosystems [ABI], Foster City, CA). Cycle sequencing was performed 
Measurement of Auditory Activity by Evoked Compound Action Potential and Evoked Stapedius Reflex
Auditory ECAPs were obtained intraoperatively using the Nucleus NRT system (Cochlear Corp., Melbourne, Australia). The Nucleus 24 cochlear implant has 22 electrodes with electrode one inserted to the basal end of the cochlea and electrode 22 at the apical end. In the NRT system, biphasic current pulses are sent to an intracochlear electrode in monopolar stimulation mode, which activates the auditory nerve to generate an ECAP. A second intracochlear electrode typically located two electrodes away in the apical direction is used to sample the voltage of the ECAP, which is transmitted to an externally worn coil and is captured by the NRT software. The sampling rate of 16 kHz shifts in onset from one sweep to the next so that the combined response is represented by an effective sampling rate of 32 kHz. A subtraction paradigm is used to eliminate stimulation artifact from the response. 9 Stimulation probes were biphasic pulses of 25 sec width delivered at 80 Hz by electrode 20 at the apical end and electrode 3 at the basal end of the cochlea. ECAPs were obtained at stimulation level amplitudes measured in "current level" units (CL) defined by Cochlear Corporation; CL units range from 1 to 255, representing a range of 10 to 1750 A and increasing in 2% steps per unit. 10 ECAP waves were plotted as a change in amplitude (V) over a time period termed latency (msec). As shown in Figure 1 , the depolarization phase is displayed as a negative peak (N1) and the repolarization phase as a positive peak (P2). ECAPs in the "cascade pane" were obtained at decreasing stimulus levels in steps of 5 CL until responses could no longer be visualized. The last level at which a wave could be visually detected was termed the visual threshold. ECAPs at each intensity level were evaluated in the "graph pane" by studying the two 16-kHz sampled waves that make up the 32-kHz composite wave and by marking the peaks N1 and P2. The ECAP amplitude was calculated by subtracting N1 from P2. The best-fit line of amplitude growth with CL was calculated in the "analysis pane" providing both the rate of amplitude growth (slope) and the threshold estimated from the x-intercept of the slope (tNRT). Amplitude and latency were evaluated at 20-CL units above threshold because the amplitude of the ECAP response has been shown to vary with stimulus level. 9 This intensity level was selected because responses at these levels could be recorded in most children.
ECAPs were marked by an evaluator (E.J.P.) who was blinded to patient variables and GJB2 status. ECAP data were analyzed using the Nucleus NRT software version 3.1 (Cochlear Corp.). A subset of 40 ECAPs from 20 individuals were randomized and evaluated by a second blinded observer. Measurements of all continuous variables were pooled, and there was a high correlation between markers (R 2 ϭ 0.994, P Ͻ .01). The ESR was evaluated intraoperatively by the cochlear implant surgeon (B.C.P.) after insertion of the implant. ESRs were evoked by three to four stimulus pulse trains of 500 ms at 900 Hz with a pulsewidth of 25 sec presented at an ISI of 500 ms. The stapedius muscle ipsilateral to the cochlear implant was evaluated using an operating microscope. Stimuli were presented at 220 CL, and a bracketing technique changing in units of 5 CL was used to identify the ESR threshold (ESRT) at the lowest level at which the ESR was visually detected. ESR measurement was attempted for all individuals at electrodes 20 and 3. The ESRT has been shown to correlate well with behavioral measures of maximal levels of comfortable electrical stimulation and typically occurs at levels above the ECAP threshold. 11 A dynamic range of stimulation was calculated as defined by the difference between the ESRT and either the visually detected ECAP threshold (visual dynamic range) or the tNRT (calculated dynamic range). Differences between measures evoked by apical and basal electrodes were analyzed using repeated-measures analyses of variance (ANOVAs) with a between-group (GJB2 vs. non-GJB2) comparison. Comparisons between groups, including demographic factors, were assessed using t-tests. Data were analyzed using SPSS version 13.0 (SPSS Inc., Chicago, IL) and significance was defined as P Ͻ .05.
RESULTS
Detection of GJB2 Mutations
In total, 301 pediatric cochlear implant users were tested for GJB2 mutations: 72 had biallelic GJB2 mutations, 32 had monoallelic GJB2 mutations, and 197 had no GJB2 mutations. Thirty-nine of the 72 subjects with biallelic GJB2 mutations had ECAP data available. Of the 197 subjects without GJB2 mutations, 102 were excluded because they had an associated syndrome or risk factors for HL that did not have a genetic basis as detailed in Table  I . Of the 95 remaining subjects without GJB2 mutations, ECAP recordings were available for 58 individuals. The GJB2 group comprised 39 patients (23 male, 16 female) with a mean age at implantation of 3.65 Ϯ 3.84 years (range, 0.40 -15.43 yrs). The non-GJB2 group comprised 58 patients (36 male, 22 female) with a mean age at implantation of 5.09 Ϯ 4.42 years (range, 0.76 -17.37 yrs). As listed in Table II , there were no differences between groups in sex, age, duration of auditory deprivation, history of hearing aid use, duration of aided hearing, implant ear, model, or depth of implant insertion.
Biallelic GJB2 mutations for the 39 subjects with ECAP data are listed in Table IV . Eleven different mutations were identified: 10 were previously identified as disease causing and one was novel. 4, 5, 13 The most common GJB2 mutation was 35delG, accounting for 66 of 79 (83.5%) mutated alleles. The novel sequence change CT28_29TG (L10W) was detected in an individual from the United Kingdom who also had biallelic 35delG mutations. We did not identify the CT28_29TG (L10W) sequence change in 50 normally hearing individuals from the United Kingdom.
The hypothesis that GJB2 mutations result in similar degrees of neural activity along the length of the cochlea was tested by investigating differences between lowand high-frequency hearing and in neural activity evoked at either end of the cochlear implant array.
Residual Hearing Measured Before Cochlear Implantation
Mean unaided preimplant audiograms for both the GJB2 and non-GJB2 groups are shown in Figure 2 . The GJB2 group demonstrated flatter losses and significantly less difference from the apical to basal end of the cochlea as compared with the non-GJB2 group (t ϭ 3.89, df ϭ 89, P Ͻ .001). Thresholds were significantly better in the non-GJB2 group at 250 Hz, 500 Hz, and 1,000 Hz as compared with the GJB2 group (t ϭ Ϫ3.22, df ϭ 85.81, P ϭ .002; t ϭ Ϫ2.53, df ϭ 94.77, P ϭ .013; t ϭ Ϫ2.69, df ϭ 91.59, P ϭ .009). Thresholds were similar across groups at 
Electrically-Evoked Responses
ECAPs evoked by both apical and basal implant electrodes were present in all children, whereas ESRs could not be visually detected in 22 children in the GJB2 group and 33 in the non-GJB2 group. Measurement means and standard deviations for GJB2 and non-GJB2 groups, detailed in Table V , showed no significant differences between groups (P Ͼ .05) bar one measure; the visual dynamic range at the basal end of the array was significantly larger in the non-GJB2 group as compared with the GJB2 group (t ϭ 2.43, df ϭ 35.65, P ϭ .02). Further analyses compared measures evoked at both ends of the implanted array in each child (Figs. 3-5 ). As shown in Figure 3 , the GJB2 group showed little difference in slope of ECAP amplitude growth between responses evoked by an apical and basal electrode. Conversely, the mean slope of amplitude growth in the non-GJB2 group decreased across electrodes and demonstrated a significantly larger difference in slope in the apical to basal direction. Repeatedmeasures ANOVAs confirmed a significant effect of electrode on slope of amplitude growth (F 1,75 ϭ 6.34, P ϭ .014) and a significant interaction effect of electrode and group on slope of amplitude growth (F 1,75 ϭ 7.17, P ϭ .009), indicating that electrode position affects the rate of amplitude growth differently for GJB2 and non-GJB2 groups. As shown in Figure 4 , ECAP amplitudes in the GJB2 group also tended to remain constant when stimulating at an apical or basal electrode. In comparison, the mean amplitude in the non-GJB2 group tended to decrease in the apical to basal direction. These trends did not reach statistical significance: no significant differences in effect of electrode on amplitude (F 1,37 ϭ 1.52, P ϭ .226) or in the interaction of electrode and group on amplitude (F 1,37 ϭ 2.95, P ϭ .094) were found.
Mean visual thresholds, shown in Figure 5 , increased between apical and basal electrodes in the same manner in the GJB2 and non-GJB2 groups. There was a significant effect of electrode on visual threshold (F 1,77 ϭ 4.19, P ϭ .044) but no interaction of electrode and group on visual threshold (F 1,77 ϭ 0.017, P ϭ .895), indicating that visual thresholds behaved in the same manner in both groups across electrodes.
Mean latencies remained relatively constant across groups and electrodes. There was no effect of electrode on latency (F 1,37 ϭ 1.66, P ϭ .206) nor was there an interaction of electrode and group on latency (ANOVA, F 1,37 ϭ 0.828, P ϭ .369). Mean tNRTs also remained relatively constant across groups and electrodes. There was no effect of electrode on tNRT (ANOVA, F 1,75 ϭ 1.33, P ϭ .253), nor was there an interaction effect of electrode and group on tNRT (ANOVA, F 1,75 ϭ 1.34, P ϭ .251).
In Figure 6 , increases in ESRTs from apical to basal electrodes are shown for both the GJB2 and non-GJB2 groups. These differences were significant (F 1,38 ϭ 6.93, P ϭ .012) and tended to be smaller in the GJB2 group (no significant interaction of electrode and group on ESRT was found [F 1,38 ϭ 2.65, P ϭ .112]).
The dynamic range between thresholds of the ESR and the ECAP were assessed. Visual and calculated dynamic ranges were computed for each of the two stimulating implant electrodes (Table V) . Differences in visual dynamic range between the apical and basal ends of the implanted array are shown for each group in Figure 7 . Only a small difference was found in the GJB2 group, whereas a significantly larger difference in the apical to basal direction was present in the non-GJB2 group (t ϭ Ϫ2.51, df ϭ 30.86, P ϭ .017). There was a significant interaction of electrode and group on visual dynamic range (F 1,33 ϭ 4.90, P ϭ .034) without an effect of electrode on visual dynamic range (F 1,33 ϭ 1.52, P ϭ .226), indicating that although the visual dynamic range does not change considerably across electrodes, the manner in which it changes is different across groups. The calculated dynamic range tended to remain constant across electrodes in the GJB2 group and to have larger differences across electrodes in the non-GJB2 group as shown in Figure 8 . However, differences from apical to basal electrodes across groups were nonsignificant (t ϭ Ϫ1.80, df ϭ 21.67, P ϭ .085), and there was no effect of electrode (F 1,32 ϭ 1.26, P ϭ .270), or interaction of electrode and group, on calculated dynamic range (F 1,32 ϭ 2.34, P ϭ .136). Asterisk (*) signifies P Ͻ .05. tNRT ϭ threshold estimated from the x-intercept of the slope; ESRT ϭ evoked stapedius reflex threshold.
DISCUSSION
GJB2 Mutation Detection
All patients had severe to profound sensorineural HL before implantation. Biallelic GJB2 mutations were identified in 72 of 301 (24%) cochlear implant users. This result is similar to Liu et al., who discovered biallelic GJB2 mutations in 34% of individuals with severe to profound HL.
Ten previously described disease causing GJB2 mutations were identified as detailed in Table IV . 4, 5, 13 The most common GJB2 mutation was 35delG, accounting for 66 of 79 (83.5%) mutated alleles. This is not surprising, because the 35delG mutation is the most frequent GJB2 mutation in the hearing-impaired population worldwide. We have previously described the individual with the T107C (L36P) mutation elsewhere. 4 The 407dupA mutation is an insertion of an adenine nucleotide after position 407 that would predict a nonsense change of tryptophan to a stop at codon 136 and would be considered a diseasecausing mutation. This mutation was previously described as 408InsA. 13 In our study, the 407dupA was identified in an individual of East Indian descent living in Trinidad and is likely disease-causing because it was not isolated in 60 normally hearing individuals from India. 14 The G109A (V37I) mutation has been described as both a benign polymorphism and a disease causing mutation but is likely disease causing because it has recently been shown to be devoid of functional activity. 15 Furthermore, in a large study of Thai individuals, those with HL were homozygous or compound heterozygotes for the V37I mutation, whereas the V37I-positive control subjects were all heterozygous. 16 
Novel GJB2 Mutations
The CT28_29TG (L10W) is a novel GJB2 sequence change identified in an individual from the United Kingdom who also had biallelic 35delG mutations. This missense change causes replacement of leucine with tryptophan at codon 10. We did not identify this mutation in 50 unrelated, normally hearing control subjects from the United Kingdom. For the purposes of this study, this individual was considered to have GJB2-related HL as a result of the presence of biallelic 35delG mutations.
Differential Patterns of Neural Activity Between Groups
Children with GJB2-related HL had greater similarities between low-and high-frequency residual hearing and between neural activity electrically evoked at apical and basal regions of the cochlea as compared with children with non-GJB2-related HL who demonstrated larger deficits in basal regions. As shown in Figure 2 , mean unaided preimplant audiograms for the GJB2 group demonstrated flatter losses and less difference from the apical to the basal end of the cochlea as compared with the non-GJB2 group who had downward sloping losses and greater differences in the apical to basal direction. Consistent with our finding, Liu reported that of 77 individuals with GJB2-related HL, 24% had flat audiograms. In GJB2-related HL, a flat audiogram may reflect changes in the composition of the endolymph, which bathes hair cells relatively equally along the length of the cochlea. Conversely, non-GJB2-related HL may involve degeneration of spiral ganglion cells with the basal turn of the cochlea more affected than the apical turn. 6 Mean thresholds in the non-GJB2 group were significantly better than those in the GJB2 group at 250 Hz, 500 Hz, and 1,000 Hz but were equal across groups at higher frequencies. This suggests that non-GJB2-related HL may confer better residual hearing at the apex of the cochlea as compared with GJB2-related HL but not at the base.
A number of findings suggested very similar neural activity evoked by apical and basal electrodes in the GBJ2 group. In Figure 3 , the mean slope of amplitude growth in the GJB2 group differed little when evoked by either an apical or basal implant electrode as compared with the non-GJB2 group, which demonstrated a significantly decreasing slope of amplitude growth and larger differences in slope of amplitude growth when stimulating from apical to basal implant electrodes. A high correlation has been demonstrated between the slope of the ECAP growth function and the number of surviving spiral ganglion cells in rats. 8 A previous temporal bone study in an individual with GJB2-related HL provided anatomic evidence for spiral ganglion survival at both ends of the cochlea. 3 In the present study, preservation of amplitude growth across the length of the cochlea in the GJB2 group provides physiological evidence for consistent preservation of spiral ganglion cells along the length of the cochlea in GJB2-related HL. Similar findings are shown in Figure 4 , which illustrates the tendency for ECAP amplitudes in the GJB2 group to remain constant across test electrodes and in the non-GJB2 group to decrease in the apical to basal direction. This is likely the result of equal preservation of spiral ganglion cells along the length of the cochlea in the GJB2 group and progressive degeneration in the apical to basal direction in the non-GJB2 group. Spiral ganglion survival has previously been found to correlate better with the slope of amplitude growth of the ECAP function as compared with individual amplitude measurements, because slopes of amplitude growth have the advantage of being less "noisy" because they are derived from a series of measurements. 8 Consistent with our other findings, ESRTs evoked at apical and basal electrodes tended to be more similar in the GJB2 group as compared with the non-GJB2 group, as displayed in Figure 6 . As depicted in Figure 7 , the visual dynamic range in the GJB2 group remained relatively constant and demonstrated only a small difference across electrodes as compared with the non-GJB2 group, which demonstrated a significantly larger difference in visual dynamic range across electrodes. Given that ECAP thresholds (visual and tNRT) were similar across groups, it was not surprising that differences between the ESR and ECAP thresholds (dynamic range) in both groups were not alike. 
Similarities Across Groups
ECAPs independently acquired at each electrode were robust and relatively similar for the GJB2 and non-GJB2 groups. This suggests that despite significantly worse residual hearing at low frequencies in the GJB2 group, both the GJB2 and non-GJB2 groups responded well to stimulation with a cochlear implant.
In Figure 5 , mean visual thresholds increased in the apical to basal direction in the same manner in the GJB2 and non-GJB2 groups. Worsening thresholds in this direction are likely the result of the larger radial distance between the electrode array and the modiolus at the base of the cochlea as compared with the apex. This should hold true even with the Nucleus Contour device, because no significant differences have been found between straight and Contour electrode arrays with respect to ECAP measures. 17 Worsening thresholds in the apical to basal direction could also be the result of greater degeneration of spiral ganglion cells at the base of the cochlea as compared with the apex, with the GJB2 group having relatively less severe degeneration than the non-GJB2 group.
Latency remained constant across groups and electrodes. Although the effect of stimulus intensity on latency has not thoroughly been investigated, latency has been assumed to remain constant by previous authors while writing programs to mark ECAPs. 10 The tNRT also remained constant across groups and electrodes. This was surprising given that visual thresholds increased significantly across electrodes in both groups. In this study, visual thresholds and tNRTs for all subjects showed a significant correlation at electrode 3 (R ϭ 0.551, P ϭ .000) but not at electrode 20 (R ϭ 0.180, P ϭ .103). Visual thresholds have previously been found to correlate better than tNRTs with postoperative threshold (T) and comfort (C) levels. 10 This suggests that the visual threshold should be used to map cochlear implant users at least at apical electrodes.
Potential Caveats
In the present study, individuals with associated syndromes or risk factors for nongenetic HL were eliminated. This may have underestimated the severity of preimplant HL in the non-GJB2 group and could account for the better residual low-frequency hearing seen in this group. However, elimination of these individuals was essential for the groups to be equal before evaluation of evoked responses. Evaluation of preimplant audiograms involved nonresponses being assigned a value of 10-dB HL higher than the maximum allowable intensity by the audiometer for a specific frequency and transducer. Because the maximum allowable intensity of the audiometer decreased at 250 Hz and 8,000 Hz, mean preimplant audiogram thresholds appeared to improve at these frequencies. This was not likely to affect the difference in mean audiogram thresholds seen across groups, because nonresponses at each frequency were equally divided across GJB2 and non-GJB2 groups. Apical to basal differences in audiogram thresholds were calculated by subtracting mean thresholds at 250 Hz from those obtained at 4,000 Hz. The 4,000-Hz frequency was used because only a small number of subjects were tested at 8,000 Hz. Threshold differences across frequencies were relative and would not have been affected by the limits of the audiometer. Maximum allowable audiometer intensities did make it difficult to determine whether hearing thresholds would have remained flat or continued to slope downward at higher frequencies.
Implications
Results from this study have important implications on our understanding of the embryology of the auditory system, the mechanism of GJB2-related HL, and success with a cochlear implant. Development of the human inner ear begins in utero with formation of the otic placode followed by hair cell proliferation. 18 Cochlear ganglion neuron afferents then innervate cochlear hair cells under the guidance of adhesive and chemotropic interactions between the axon and target hair cells. 18 In the present study, individuals with GJB2-related HL demonstrated robust ECAPs despite having dysfunctional hair cells, suggesting that either functional hair cells are not essential for appropriate spiral ganglion development or that hair cell dysfunction in GJB2-related HL occurs after connections between spiral ganglion afferents and cochlear hair cells have already been established.
GJB2-related HL is presumed to result from accumulation of potassium in cochlear endolymph leading to hair cell dysfunction. 1, 2 This theory is supported by immunohistochemical studies in the rat cochlea 2 and on a postmortem human temporal bone investigation. 3 To the au- thors' knowledge, results from the present study provide the first physiological evidence in live humans for more consistent spiral ganglion survival along the length of the cochlea in GJB2-related HL as compared with non-GJB2-related deafness.
Clinically, results from this study prove that successful rehabilitation with a cochlear implant is possible in individuals with and without GJB2-related HL. Knowing that individuals with GJB2-related HL have, on average, more consistent spiral ganglion survival along the length of the cochlea than individuals without GJB2-related HL may prove useful in customizing cochlear implants for specific types of deafness. For example, current cochlear implant strategies allocate ranges of frequencies to individual electrodes with smaller ranges allocated to apical electrodes and larger ranges to basal electrodes. Because individuals with GJB2 mutations have more consistent spiral ganglion survival along the length of the cochlea, they may benefit from a more equal distribution of frequencies along the length of the electrode array. Similarly, cochlear implant users with GJB2 mutations may benefit from equal gain across all electrodes as compared with individuals without GJB2 mutations, who may receive greater benefit from higher gain at basally situated electrodes.
The rate of ECAP growth has been found to correlate significantly with the behavioral dynamic range of loudness limits (range from C to T level) in cochlear implant users. 10 Determination of the dynamic range of loudness limits is a lengthy procedure that must be repeated frequently. Because the rate of ECAP growth in GJB2-related HL is constant across electrodes, perhaps dynamic ranges in individuals known to have GJB2 mutations need to be determined at only a few electrodes and can be assumed to be equal for the rest.
Lastly, relative preservation of spiral ganglion neurons at the base of the cochlea in GJB2-related HL may allow for better perception of high-frequency stimuli such as fire alarms, musical harmonics, and speech sounds conveyed by consonants. Future investigation of these areas will shed light on whether the differences we have seen in the auditory nerves of individuals with and without GJB2-related HL translate into everyday performance with a cochlear implant.
CONCLUSION
Our study provides physiological evidence for more consistent spiral ganglion survival along the length of the cochlea in GJB2-related HL as compared with non-GJB2-related HL. The latter appears to involve a decreasing gradient of spiral ganglion survival from the apex to the base of the cochlea. Our results suggest that, in GJB2-related HL, dysfunction of gap junctions likely occurs to a similar degree in the apical and basal regions of the cochlea. Prior knowledge of the cochlear pattern of degeneration (including its prediction based on genetic testing) could be used to customize implantable devices for future patients.
